Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

BRACE trial

- PMLiVE

Britain ramps up COVID-19 testing to track spread of infections

Regular testing will increase from 28,000 people per fortnight to 150,000 by October

- PMLiVE

Vaccine nationalism must be prevented, says WHO director-general

Tedros Adhanom Ghebreyesus warns against supply nationalism

- PMLiVE

Matt Hancock unveils new National Institute for Health Protection

Public Health England to be replaced with new government body

AstraZeneca AZ

AZ inks deal with EU for 400 million doses of COVID-19 vaccine

Doses will be available to all EU member states at no profit during pandemic

- PMLiVE

Public Health England to be axed over coronavirus response

Report from The Sunday Telegraph details plans to replace agency

- PMLiVE

COVID-19 vaccine approval unlikely before November, says US NIH director

US National Institutes of Health Director Francis Collins cautioned against unrealistic timelines

- PMLiVE

UK agrees on COVID-19 vaccine deals with J&J and Novavax

Initial agreement secures 90 million doses

- PMLiVE

BMS pledges $300m to tackle health inequity and improve diversity

Drugmaker announces a series of commitments to expand inclusion

- PMLiVE

Vir Biotech plans to start mid-to-late stage study of COVID-19 antibody this month

Monoclonal antibody has neutralised SARS-CoV-2 virus in vitro

- PMLiVE

Russia becomes first country to approve a COVID-19 vaccine

Vaccine approved after less than two months of human testing

- PMLiVE

US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine

Latest deal is part of Operation Warp Speed

- PMLiVE

Novavax plans to meet US COVID-19 vaccine demand in 2021

Company plans to produce two billion doses if vaccine proves effective

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links